CCL2 chemokine inhibition primes the tumor vasculature for improved nanomedicine delivery and efficacy.
J Control Release
; 365: 358-368, 2024 Jan.
Article
in En
| MEDLINE
| ID: mdl-38016488
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Chemokine CCL2
/
Neoplasms
Limits:
Animals
Language:
En
Journal:
J Control Release
Year:
2024
Document type:
Article